GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedAdvisor Ltd (ASX:MDR) » Definitions » EBIT

MedAdvisor (ASX:MDR) EBIT : A$-5.9 Mil (TTM As of Dec. 2023)


View and export this data going back to 2011. Start your Free Trial

What is MedAdvisor EBIT?

MedAdvisor's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was A$8.2 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was A$-5.9 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. MedAdvisor's annualized ROC % for the quarter that ended in Dec. 2023 was 16.22%. MedAdvisor's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1,490.09%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. MedAdvisor's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -2.56%.


MedAdvisor EBIT Historical Data

The historical data trend for MedAdvisor's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedAdvisor EBIT Chart

MedAdvisor Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -8.09 -9.66 -16.81 -16.19 -8.38

MedAdvisor Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.95 -9.24 5.79 -14.17 8.23

Competitive Comparison of MedAdvisor's EBIT

For the Health Information Services subindustry, MedAdvisor's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MedAdvisor's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedAdvisor's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MedAdvisor's EV-to-EBIT falls into.



MedAdvisor EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-5.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedAdvisor  (ASX:MDR) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

MedAdvisor's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

ROC % (Q: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2023 ) + Invested Capital (Q: Dec. 2023 ))/ count )
=15.58 * ( 1 - 3.7% )/( (86.609 + 98.407)/ 2 )
=15.00354/92.508
=16.22 %

where

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

MedAdvisor's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2023 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jun. 2023  Q: Dec. 2023
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=16.458/( ( (1.371 + max(-21.231, 0)) + (0.838 + max(-18.216, 0)) )/ 2 )
=16.458/( ( 1.371 + 0.838 )/ 2 )
=16.458/1.1045
=1,490.09 %

where Working Capital is:

Working Capital(Q: Jun. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.982 + 0 + 2.18) - (14.364 + 0.543 + 17.486)
=-21.231

Working Capital(Q: Dec. 2023 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(28.431 + 0 + 2.293) - (29.19 + 0.527 + 19.223)
=-18.216

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

MedAdvisor's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2023 )
=-5.941/232.239
=-2.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MedAdvisor EBIT Related Terms

Thank you for viewing the detailed overview of MedAdvisor's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


MedAdvisor (ASX:MDR) Business Description

Traded in Other Exchanges
N/A
Address
971 Burke Road, Level 2, Camberwell, VIC, AUS, 3124
MedAdvisor Ltd is engaged in the development and deployment of the MedAdvisor medication and adherence platform. The MedAdvisor platform is focused on improving health outcomes by connecting health professionals with their patients using mobile and web technologies. It has five reporting segments: ANZ Operations, USA Operations, UK Operations, Asia Operations, and Corporate. The company derives majority of its revenues from AU Operations.

MedAdvisor (ASX:MDR) Headlines

No Headlines